MannKind Corp
MNKD
#6155
Rank
โ‚ฌ0.94 B
Marketcap
2,94ย โ‚ฌ
Share price
-3.80%
Change (1 day)
-30.20%
Change (1 year)

MannKind Corp (MNKD) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚ฌ0.29 Billion

According to MannKind Corp's latest financial reports the company's total debt is โ‚ฌ0.29 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

MannKind Corp - Total debt on balance sheet (from 2006 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ0.31 B549.44%
2024-12-31โ‚ฌ48.16 M-80.47%
2023-12-31โ‚ฌ0.24 B-5.13%
2022-12-31โ‚ฌ0.25 B4.3%
2021-12-31โ‚ฌ0.24 B148.34%
2020-12-31โ‚ฌ0.10 B-7.41%
2019-12-31โ‚ฌ0.10 B20.98%
2018-12-31โ‚ฌ89.58 M-31.46%
2017-12-31โ‚ฌ0.13 B-7.42%
2016-12-31โ‚ฌ0.14 B-27.9%
2015-12-31โ‚ฌ0.19 B5.88%
2014-12-31โ‚ฌ0.18 B2.05%
2013-12-31โ‚ฌ0.18 B-27.73%
2012-12-31โ‚ฌ0.25 B-33.25%
2011-12-31โ‚ฌ0.37 B12.37%
2010-12-31โ‚ฌ0.33 B72.43%
2009-12-31โ‚ฌ0.19 B90.53%
2008-12-31โ‚ฌ0.10 B32.94%
2007-12-31โ‚ฌ76.54 M-9.23%
2006-12-31โ‚ฌ84.32 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚ฌ56.39 B 19,000.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚ฌ19.09 B 6,367.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚ฌ48.99 B 16,496.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ48.10 B 16,193.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚ฌ1.91 B 548.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ70.1 M-76.26%๐Ÿ‡บ๐Ÿ‡ธ USA